Pharmacologic Characteristics of Indinavir, Didanosine, and Stavudine in Human Immunodeficiency Virus-Infected Children Receiving Combination Therapy

The use of human immunodeficiency virus (HIV) protease inhibitors in children has lagged behind that in adults because of the lack of suitable pediatric formulations and information on safe and effective dosing regimens. This study was designed to obtain pharmacokinetic information on indinavir, adm...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Fletcher, Courtney V., Brundage, Richard C., Remmel, Rory P., Page, Linda M., Weller, Dennis, Calles, Nancy R., Simon, Cara, Kline, Mark W.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89808/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10722507/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.4.1029-1034.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!